Clade-Specific Evolution Mediated by HLA-B*57/5801 in Human Immunodeficiency Virus Type 1 Clade A1 p24

被引:12
|
作者
McKinnon, Lyle R. [1 ,2 ]
Capina, Rupert [4 ]
Peters, Harold [4 ]
Mendoza, Mark [4 ]
Kimani, Joshua [1 ,2 ]
Wachihi, Charles [1 ]
Kariri, Anthony [1 ]
Kimani, Makobu [1 ]
Richmond, Meika [2 ]
Kiazyk, Sandy Koesters [5 ]
Fowke, Keith R. [1 ,2 ]
Jaoko, Walter [1 ]
Luo, Ma [4 ]
Ball, T. Blake [1 ,2 ,3 ,5 ]
Plummer, Francis A. [1 ,2 ,4 ,5 ]
机构
[1] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[2] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
[3] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada
[4] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada
[5] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Winnipeg, MB, Canada
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
T-CELL RESPONSES; VIRAL REPLICATION CAPACITY; LONG-TERM NONPROGRESSORS; HIV-1; INFECTION; CROSS-REACTIVITY; ESCAPE MUTATIONS; HLA ALLELES; CLASS-I; GAG; EPITOPE;
D O I
10.1128/JVI.01236-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HLA-B*57-mediated selection pressure leads to a typical escape pathway in human immunodeficiency virus type 1 (HIV-1) CD8 epitopes such as TW10. Whether this T242N pathway is shared by all clades remains unknown. We therefore assessed the nature of HLA-B*57 selection in a large, observational Kenyan cohort where clades A1 and D predominate. While T242N was ubiquitous in clade D HLA-B*57(+) subjects, this mutation was rare (15%) in clade A1. Instead, P243T and I247L were selected by clade A1-infected HLA-B*57 subjects but not by HLA-B*5801(+) subjects. Our data suggest that clade A1 consensus proline at Gag residue 243 might represent an inherent block to T242N escape in clade A1. We confirmed immunologically that P243T and I247L likely represent escape mutations. HLA-B*57 evolution also differed between clades in the KF11 and IW9 epitopes. A better understanding of clade-specific evolution is important for the development of HIV vaccines in regions with multiple clades.
引用
收藏
页码:12636 / 12642
页数:7
相关论文
共 44 条
  • [31] Reduced Viral Replication Capacity of Human Immunodeficiency Virus Type 1 Subtype C Caused by Cytotoxic-T-Lymphocyte Escape Mutations in HLA-B57 Epitopes of Capsid Protein
    Boutwell, Christian L.
    Rowley, Christopher F.
    Essex, M.
    JOURNAL OF VIROLOGY, 2009, 83 (06) : 2460 - 2468
  • [32] Selection of HLA-B57-associated Gag A146P mutant by HLA-B*48:01-restricted Gag140-147-specific CTLs in chronically HIV-1-infected Japanese
    Naruto, Takuya
    Murakoshi, Hayato
    Chikata, Takayuki
    Koyanagi, Madoka
    Kawashima, Yuka
    Gatanaga, Hiroyuki
    Oka, Shinichi
    Takiguchi, Masafumi
    MICROBES AND INFECTION, 2011, 13 (8-9) : 766 - 770
  • [33] HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E
    Paris, Robert
    Bejrachandra, Sasitorn
    Thongcharoen, Prasert
    Nitayaphan, Sorachai
    Pitisuttithum, Punnee
    Sambor, Anna
    Gurunathan, Sanjay
    Francis, Donald
    Ratto-Kim, Silvia
    Karnasuta, Chitraporn
    de Souza, Mark S.
    Polonis, Victoria R.
    Brown, Arthur E.
    Kim, Jerome H.
    Stephens, Henry A.
    VACCINE, 2012, 30 (05) : 832 - 836
  • [34] Low-cost simultaneous detection of CCR5-delta32 and HLA-B*5701 alleles in human immunodeficiency virus type 1 infected patients by selective multiplex endpoint PCR
    Rosi, Andrea
    Meini, Genny
    Materazzi, Angelo
    Vicenti, Ilaria
    Saladini, Francesco
    Zazzi, Maurizio
    JOURNAL OF VIROLOGICAL METHODS, 2015, 224 : 102 - 104
  • [35] IN-VIVO INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC CYTOTOXIC T-LYMPHOCYTES AND DELAYED-TYPE HYPERSENSITIVITY BY A 23-AMINO ACID PEPTIDE FROM THE HIGHLY CONSERVED REGION IN MAJOR CORE PROTEIN P24
    NISHINO, Y
    KAMEOKA, M
    OKADA, Y
    ZHONG, Q
    KIMURA, T
    AZUMA, I
    IKUTA, K
    VACCINE, 1994, 12 (06) : 485 - 491
  • [36] Comparisons of DNA-mediated immunization procedures directed against surface glycoproteins of human immunodeficiency virus type-1 and hepatitis B virus
    Fomsgaard, A
    Nielsen, HV
    Nielsen, C
    Johansson, K
    Machuca, R
    Bruun, L
    Hansen, J
    Buus, S
    APMIS, 1998, 106 (06) : 636 - 646
  • [37] Inhibition of microtubules and dynein rescues human immunodeficiency virus type 1 from owl monkey TRIMCyp-mediated restriction in a cellular context-specific fashion
    Pawlica, Paulina
    Dufour, Caroline
    Berthoux, Lionel
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 874 - 886
  • [38] The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8+ T cell responses
    Melhem, Nada M.
    Smith, Kellie N.
    Huang, Xiao-Li
    Colleton, Bonnie A.
    Jiang, Weimin
    Mailliard, Robbie B.
    Mullins, James I.
    Rinaldo, Charles R.
    VIROLOGY, 2014, 450 : 34 - 48
  • [39] Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p5l antigens
    Kmieciak, D
    Bolesta, E
    Naito, T
    Gzyl, J
    Kaneko, Y
    Kozbor, D
    JOURNAL OF HUMAN VIROLOGY, 2001, 4 (06) : 306 - 316
  • [40] Low or no antibody responses to human immunodeficiency virus type 1 Nef in infected carriers with subtype E, in contrast to subtype B that showed antibodies preferentially recognizing subtype-specific Nef epitopes
    Komoto, S
    Kinomoto, M
    Ibrahim, MS
    Qiu, Z
    Auwanit, W
    Ayuthaya, PIN
    Otake, T
    Mori, H
    Oishi, I
    Kurosu, T
    Takahashi, H
    Mukai, T
    Ikuta, K
    VACCINE, 2001, 19 (20-22) : 3019 - 3032